Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

SECUKINUMAB 300 mg Pre-filled Injection 1 Pen Pack

Belfast Health and Social Care Trust

This public procurement record has 3 releases in its history.

Award

29 Sep 2026 at 11:32

UK7 - Contract Details Notice
Award

08 Sep 2026 at 10:32

UK6 - Contract Award Notice
Award

07 Sep 2026 at 13:39

UK5 - Transparency Notice
Summary of the contracting process

Belfast Health & Social Care Trust procured secukinumab 300 mg pre-filled injection pens, supplied in packs of one. This is a branded pharmaceutical product for patient care, rather than a broader medicines supply or clinical service contract. The goods are for delivery in the United Kingdom; no more specific delivery location is identified. The requirement covers one lot and concerns a single named medicine and strength. The stated rationale is that the medicine is patent-protected, essential to patient care and available from only one economic operator. This makes the procurement a product-specific requirement, rather than a competition across alternative medicines or suppliers.

The procurement is complete and the contract is active. The Trust used a direct award, citing patent protection and availability from a single economic operator; the process was evaluated on that basis. Novartis Pharmaceuticals UK Limited was selected for the single lot. The award was made on 8 September 2026, and the contract was signed on 29 September 2026. The awarded and contracted value is £280,000. The contract period runs from 29 September 2026 to 30 September 2028. The procurement concerns a single product, with no additional lot distinctions. The recorded rationale for bypassing competition was that the product is essential to patient care and the lack of competition did not result from artificially narrowing the procurement requirements.

For suppliers assessing future requirements from Belfast Health & Social Care Trust, this award demonstrates demand for a specific branded, patent-protected medicine: secukinumab 300 mg pre-filled injection pens in single-pen packs. A credible supplier would need the rights and ability to supply that exact medicinal product, with the necessary pharmaceutical supply capability to meet the Trust’s patient-care requirement. The award was made directly because the Trust considered the product available from only one economic operator, so a supplier of alternatives or general pharmaceutical products would not meet the stated basis for this purchase. The requirement was for one product and one lot, indicating a focused supply rather than a multi-product medicines portfolio. The appointed supplier was a large pharmaceutical company, reflecting the specialist nature of the product supply.】【”】【}_.final>xpath хитайға}

How relevant is this notice?

Notice Information

Notice Title

SECUKINUMAB 300 mg Pre-filled Injection 1 Pen Pack

Notice Description

Procurement of SECUKINUMAB 300 mg Pre-filled Injection 1 Pen Pack

Procurement Information

These are branded patent protected medicines that are essential to patient care and are available from only one economic operator. The absence of competition is not a result of the artificial narrowing of the parameters of the procurement.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06f385
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/091764-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Direct award
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
£280,000 £100K-£500K
Contracts Value
£280,000 £100K-£500K

Notice Dates

Publication Date
29 Sep 20261 weeks ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
8 Sep 20261 months ago
Contract Period
29 Sep 2026 - 30 Sep 2028 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Belfast Health and Social Care Trust
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
BELFAST
Postcode
BT12 6BA
Postcode Area
Northern Ireland
Country
Northern Ireland
Major Region (ITL 1)
TLN Northern Ireland
Basic Region (ITL 2)
TLN0 Northern Ireland
Small Region (ITL 3)
TLN06 Belfast
Delivery Location
Not specified
Local Authority
Belfast
Electoral Ward
Falls
Westminster Constituency
Belfast West

Supplier Information

Number of Suppliers
1
Supplier Name

Novartis Pharmaceuticals UK Ltd

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...